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Abstract
The Thailand-Cambodia border is the epicenter for drug-resistant falciparum malaria. Previous studies have shown that
chloroquine (CQ) and pyrimethamine resistance originated in this region and eventually spread to other Asian countries and
Africa. However, there is a dearth in understanding the origin and evolution of dhps alleles associated with sulfadoxine
resistance. The present study was designed to reveal the origin(s) of sulfadoxine resistance in Cambodia and its evolutionary
relationship to African and South American dhps alleles. We sequenced 234 Cambodian Plasmodium falciparum isolates for
the dhps codons S436A/F, A437G, K540E, A581G and A613S/T implicated in sulfadoxine resistance. We also genotyped 10
microsatellite loci around dhps to determine the genetic backgrounds of various alleles and compared them with the
backgrounds of alleles prevalent in Africa and South America. In addition to previously known highly-resistant triple mutant
dhps alleles SGEGA and AGEAA (codons 436, 437, 540, 581, 613 are sequentially indicated), a large proportion of the isolates
(19.3%) contained a 540N mutation in association with 437G/581G yielding a previously unreported triple mutant allele,
SGNGA. Microsatellite data strongly suggest the strength of selection was greater on triple mutant dhps alleles followed by
the double and single mutants. We provide evidence for at least three independent origins for the double mutants, one
each for the SGKGA, AGKAA and SGEAA alleles. Our data suggest that the triple mutant allele SGEGA and the novel allele
SGNGA have common origin on the SGKGA background, whereas the AGEAA triple mutant was derived from AGKAA on
multiple, albeit limited, genetic backgrounds. The SGEAA did not share haplotypes with any of the triple mutants.
Comparative analysis of the microsatellite haplotypes flanking dhps alleles from Cambodia, Kenya, Cameroon and Venezuela
revealed an independent origin of sulfadoxine resistant alleles in each of these regions.
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Introduction
The Thailand-Cambodia border in Southeast Asia has been an
epicenter for drug resistant falciparum malaria where chloroquine
(CQ) resistance emerged in the early 1960s [1], followed by
sulfadoxine-pyrimethamine (SP) resistance in the late 1970s [2,3]
and mefloquine (MQ) resistance in the mid 1990s [4]. Following
the emergence of MQ resistance, artemisinin-based combination
therapy (ACT) consisting of artesunate (AS) and MQ was adopted
as the first-line treatment against uncomplicated falciparum
malaria in Thailand (1995) and Cambodia (2000) [4,5].
Sulfadoxine-pyrimethamine (SP) combination is the most widely
used antifolate to treat CQ-resistant falciparum malaria and, because
oftheir synergisticeffect, thecombinationismoreeffectivethaneither
drug used alone [6,7,8]. It is also one of the partner drugs of
artemisinin-based combination therapy (ACT) currently being used
for treatment of uncomplicated falciparum malaria in some parts of
the world [9]. Importantly, SP is the only drug recommended by the
World Health Organization (WHO) for intermittent preventive
treatment (IPT) in pregnant women in Sub-Saharan Africa where
large number of deaths occur due to malaria in pregnancy [9].
Sulfadoxine acts by inhibiting dihydropteroate synthase (dhps), an
essential enzyme of the folate biosynthesis pathway [10]. Previous
studies have identified mutations at five DHPS codons (S436A/F;
A437G; K540E; A581G; and A613S/T) to be associated with
sulfadoxine resistanceinP.falciparum[11,12,13,14,15]. Kinetic studies
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sulfadoxine, resulting in the development of resistance, the level of
which broadly correlates with the number of mutations in dhps [13].
In Southeast Asia, at least two different triple mutant dhps alleles
(AGEAA and SGEGA) have been described [16,17,18] whereas in
South America, a single triple mutant allele SGEGA has been
reported [19,20,21,22,23]. Interestingly in Africa, the SGEAA
(east Africa) and AGKAA (west and central Africa) double mutants
are the common dhps alleles [24,25], with no triple mutant dhps
alleles reported on this continent thus far. Similarly, the
pyrimethamine-resistant quadruple mutant dhfr allele (51I/59R/
108N/164L) is abundant in Southeast Asia and in low frequency
in Africa [26,27]. The triple mutant dhfr allele 51I/59R/108N
is widespread in Southeast Asia and Africa, whereas in South
America (mostly in the Peruvian Amazon) two other forms
of the triple mutant (50R/51I/108N and 51I/108N/164L) are
prevalent.
Microsatellite analysis has revealed that triple (51I/59R/108N)
mutant dhfr alleles in Africa have shared ancestry with dhfr alleles
from Southeast Asia suggesting that, like CQ resistance, the alleles
conferring pyrimethamine resistance were also introduced into
Africa from Southeast Asia [25,26,27,28,29,30,31,32,33]. Howev-
er, unlike Southeast Asia where all dhfr alleles have single common
ancestor [26], additional local evolution of the dhfr alleles has been
reported in Africa [25,27,28,34,35]. In South America, the
pyrimethamine-resistant dhfr alleles are thought to have two
independent origins [20,21,22]. Recently, another independent
origin of the double mutant dhfr allele (59R/108N) has been
observed in Papua New Guinea [36]. Thus, similar to CQ
resistance, at least four major distinct origins of pyrimethamine
resistance have been reported worldwide.
Although the origins of CQ and pyrimethamine resistance are
better understood, there is limited data related to the origins of
sulfadoxine resistance globally. Previous studies have reported
multiple and independent origins of double mutant dhps alleles in
Africa [24,25,37], and one common origin for the triple mutant
dhps allele in South America [20,21,22]. Importantly, the origins of
the three different double mutants (AGKAA, SGKGA and
SGEAA) and two different triple mutant (AGEAA and SGEGA)
dhps alleles remain unknown in Southeast Asia. Therefore, the
present study was aimed to (i) determine whether resistant dhps
alleles in Cambodia are experiencing a selective sweep (ii) estimate
the probable number of origins of the highly resistant dhps alleles in
Cambodia and (iii) examine the evolutionary relationships
between Southeast Asian (Cambodia), South American (Vene-
zuela) and African (Cameroon and Kenya) dhps alleles.
Materials and Methods
Sample collection, DNA isolation and genotyping for
dhps codons 436 to 613
Plasmodium falciparum clinical isolates were collected from
patients with uncomplicated falciparum malaria from five sites in
Cambodia: Pailin and Kampong Seila in the west, Chumkiri in the
south, and Memut and Rattanakiri in the east (Fig. 1). Patients
enrolled in this study were treated with ACT (Artesunate+Me-
floquine) according to the national drug policy of Cambodia.
Written informed consent was obtained from each patient before
blood collection. The study was approved by Institutional Review
Boards (IRBs) of the Cambodia National Ethics Committee for
Health Research, the US Naval Medical Research Unit No. 2
(NAMRU-2) Jakarta, Indonesia, and the University of North
Carolina at Chapel Hill (UNC), USA.
DNA was extracted from filter paper blood spots using QIAmp
Mini kit (Qiagen, Valencia, CA, USA). A total of 234 P. falciparum
isolates (Pailin, n=51; Kampong Seila, n=10; Chumkiri, n=85;
Memut, n=43; and Rattanakiri, n=45) were sequenced for a
portion of the dhps gene covering codons 436, 437, 540, 581 and
613. Each DNA sample representing a clinical isolate was
subjected to two rounds of PCR. The primary amplification was
done using 59-AACCTAAACGTGCTGTTCAA-39 (Forward)
and 59-AATTGTGTGATTTGTCCACAA-39 (Reverse) primers
with the following cycling parameters: 5 minutes initial denatur-
ation at 95uC followed by 35 cycles with 30 seconds denaturation
at 95uC, 30 seconds annealing at 50uC, 1 minute extension at
68uC and a final 5 minute extension at 68uC. The primary
amplification product was subjected to nested PCR using 59-
ATGATAAATGAAGGTGCTAG-39 (Forward) and 59-TCATT-
TTGTTGTTCATCATGT-39 (Reverse) primers with the same
cycling parameters as primary except that the annealing was done
at 52uC and the number of cycles was reduced to 30. The 647 bp
nested product was sequenced on an ABI 3130xl Genetic Analyzer
(Applied Biosystems, Foster City, CA, USA).
Microsatellite analysis
Parasite isolates with mixed dhps sequencing electropherograms
(multiple peaks at one or more nucleotide) were removed from the
microsatellite analysis. Only those with single dhps genotypes were
assayed for 8 neutral microsatellite loci on chromosomes 2
(GenBank UniSTS ID: C2M27, C2M29, C2M34, C2M33) and
3 (GenBank UniSTS ID: C3M40, C3M88, C3M69 and C3M39)
in order to exclude any additional multiply-infected samples and
to obtain an estimate of the neutral baseline heterozygosity in the
population [38]. These loci have previously been used for
constructing a genetic map of P. falciparum and are not known to
be under the influence of any selection [38]. PCR cycling
parameters for all 8 neutral loci were adapted from Nair et al
[26] as described earlier [21]. Isolates containing multiple alleles at
one or more loci on chromosomes 2 and/or 3 were not carried
forward for analyzing microsatellites on chromosome 8 around the
Author Summary
Widespread resistance to chloroquine (CQ) and sulfadox-
ine-pyrimethamine (SP), the two least expensive and
widely available antimalarial drugs, has become a major
global public health challenge. It is known that point
mutations in Plasmodium falciparum crt, dhfr and dhps
genes contribute to resistance to CQ, pyrimethamine and
sulfadoxine, respectively. CQ and pyrimethamine resis-
tance spread to Africa and Asia from a few founding
mutant lineages originating from the Thailand-Cambodia
border. Here, we define the origins of dhps alleles in
Cambodia and their relationships to African and South
American counterparts. Three different triple mutant
alleles including a novel allele comprised of 437G, 540N,
and 581G mutations (S436G437N540G581A613) were found
in Cambodia as opposed to a single triple mutant allele in
South America and two common double mutant alleles in
Africa. Microsatellite data suggest strong selection oper-
ating on triple mutant alleles as compared to double and
single mutants in Cambodia. We report three major
independent origins for the double mutants and at least
two independent origins for the highly resistant triple
mutant dhps alleles in Cambodia. We also show that the
resistant dhps alleles in Africa and South America have
distinct origins from Cambodia. These results suggest that
the evolution and spread of sulfadoxine resistance is
different from CQ and pyrimethamine resistance.
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loci, five upstream (211 Kb, 27.5 Kb, 22.9 Kb, 21.5 Kb,
20.13 Kb) and five downstream (0.03 Kb, 0.5 Kb, 1.4 Kb,
6.4 Kb and 9 Kb) of the dhps gene. Primer sequences and PCR
cycling parameters for these loci are provided as supporting
information available online (Table S1). The amplified PCR
products were separated on ABI 3130xl Genetic Analyzer and
analyzed using GeneMapper software v3.7 (Applied Biosystems,
Foster City, CA, USA).
Testing selection and genetic differentiation
To estimate the genetic variability at each of the 10 loci on
chromosome 8 flanking dhps, we calculated number of alleles (A) as
well as expected heterozygosity (He) per locus using GenAlEx 6.2
[39]. He was calculated using the formula (He)=[n/(n21)][12Spi
2],
where n is the number of P. falciparum isolates genotyped for that
locus and pi is the frequency of the ith allele. The sampling variance
for He was calculated as 2(n21)/n
3 {2(n22) [S(pi
32(Spi
2)
2]}. In
order to investigate whether a selective sweep had occurred around
dhps alleles, we divided the entire sample set into groups based on
either the number of mutations (wild type, single, double and triple
mutant group) or type of mutations/genotype (e.g. SGEAA) in the
dhps gene. Significant difference between the mean He of any two
groupswasassessed usingtheMann-WhitneyU test implementedin
the statistical package Stata version 8.1 for Windows (Stata
Corporation, College Station, TX, USA). Differences were
considered significant if the calculated P value was #0.05 (two-
tailed test). Since microsatellite loci adjacent to a gene under
selection (here dhps) may behave as non-neutral because of
hitchhiking, we also performed similar analyses for 8 loci on
chromosomes 2 and 3 which are putatively neutral.
We estimated FST between populations (following Weir and
Cockerham)[40]at 10 dhpsand8neutral microsatellite lociusing the
software GDA [41]. The populations were defined as wild, single,
double and triple mutants according to the number of mutations
in the dhps gene. 95% confidence intervals (CI) for each estimate
and the standard deviation (SD) respectively, were computed by
bootstrapping (over loci) and jackknifing (over population and loci)
with 1000 permutations. To test whether FST at dhps loci differed
from that of the neutral loci, we used Mann-Whitney U test.
It has been shown that loci directly under selection or linked to a
selected loci exhibit extremely low or high levels of genetic
differentiation between populations (FST) as compared to neutral
loci [42,43,44,45,46,47,48]. Such outlier loci can be identified by
the coalescent simulations method of Beaumont and Nichols [43]
where the FST distribution is plotted as a function of He across loci
under an island model of migration. We used this approach to
disentangle selected from unselected loci, using FDIST program
implemented in the software LOSITAN [49]. Simulations were
initially run (under infinite-allele model) for only 8 neutral loci to
calculate the mean neutral FST value which was subsequently used
as ‘‘forced mean FST’’ to run the second round of simulation along
with all 10 dhps loci. The 95% confidence interval was achieved
with 10,000 simulations of 4 expected populations with sample size
of 50.
To assess whether there was underlying population structure that
would bias our conclusions regarding selection, we used FSTAT
2.9.3.2 [50] to partition the variation in the population using both
dhps and neutral loci. Here we considered each geographical site
(Pailin, Chumkiri, Memut and Rattanakiri) as a discrete population
to calculate FST (using 1000 permutations). Since there were only 7
singly-infected isolates from Kampong Seila and is located in
western Cambodia, they were grouped along with Pailin.
The strength of linkage disequilibrium across all 10 loci around
dhps alleles was estimated as standardized index of association (IA
S),
a haplotype-wide measure of linkage [51,52] using LIAN version
3.5 [53]. IA
S was calculated using the formula IA
S=(V D/Ve21)/
(L21) where VD is the observed mismatch variance, Ve is the
expected mismatch variance and L is the number of loci tested.
The null hypothesis of complete linkage equilibrium (IA
S=0) was
tested by the Monte-Carlo simulation process using 10,000
random permutations of the data.
Determining the number of origins for dhps alleles
To examine the probable number of origins of sulfadoxine-
resistant dhps alleles in Cambodia, a median-joining network was
Figure 1. The map of Cambodia showing study sites. The pie-diagrams show the frequency distribution of the single, double, triple and
quadruple mutant dhps alleles in Cambodia. PL, Pailin; KS, Kampong Seila; CK, Chumkiri; MM, Memut; RK, Rattanakiri.
doi:10.1371/journal.ppat.1000830.g001
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4.5.1.0 (http://www.fluxus-engineering.com/sharenet.htm). Me-
dian-joining networks are used for reconstructing the phylogeny of
regions with reticulate evolution [54]. In order to understand the
genetic relationships among the dhps alleles of Southeast Asia
(Cambodia), Africa (Kenya and Cameroon) and South America
(Venezuela) an eBURST (version 3) analysis [55] was performed.
We used only 7 loci (211 Kb, 27.5 Kb, 22.9 Kb, 20.13 Kb,
0.03 Kb, 0.5 Kb, 1.4 Kb) for this comparison as data for the other
3 loci were not available for African and South American isolates.
Data for African and South American isolates were obtained from
a previous study from our laboratory [37].
Results
Removal of multiply-infected samples
The region of the dhps gene containing codons 436, 437, 540,
581 and 613 was sequenced in 234 Cambodian P. falciparum
isolates (Fig. 1). Out of these, 22 (,9%) isolates contained mixed
alleles at one or more dhps codons based on multiple peaks in the
sequencing electropherograms (see Table S2 for mixed dhps
genotypes) while 212 had single genotype at all 5 dhps codons
based on single peaks in the sequencing electropherograms at
each nucleotide. These 212 samples were subjected to neutral
microsatellite (8 loci) analysis and 71 were found to contain
multiple alleles at one or more neutral loci. Since it is not easy to
construct unambiguous microsatellite haplotypes using the samples
with multiple infections [26,56], these 71 multiply-infected samples
were excluded and only 141 single clonal samples were typed for
microsatellites on chromosome 8 around the dhps gene. Therefore,
we present here the dhps codon distribution for 212 isolates
(Table 1) and dhps microsatellites data for 141 isolates.
A novel triple mutant dhps allele in Cambodia
Approximately 11% of the isolates, mostly from the east, had
the ancestral wild type dhps allele S436A437K540A581A613 (SAKAA).
None of the isolates from the west had the ancestral wild type allele
(Table 1). We observed mutations at all five dhps codons implicated
in sulfadoxine resistance, with striking differences in the regional
distribution of dhps mutations in Cambodia. The dhps allele with
the single 437G (SGKAA) mutation was seen in ,10% of the
isolates, mostly in the east. However, 437G alone or along with
other dhps mutations were found in almost 89% of the isolates
(Table 1). Collectively, the double mutant dhps alleles were found
in nearly 27% of the isolates in either of three combinations,
436A/437G (AGKAA, 7.5% mostly in the east); 437G/581G
(SGKGA, 7.5%, predominantly in the south and west); and
437G/540E (SGEAA, 11.3%, mostly in the south and east).
Approximately 51% of the isolates harbored triple mutations of
either 436A/437G/540E (AGEAA, 20.7%), 437G/540E/581G
(SGEGA, 10.3%), the novel genotype 437G/540N/581G
(SGNGA, 19.3%) or 436A/437G/613E (AGKAT, 0.47%). The
alleles with triple mutations were predominant in western and
southern Cambodia whereas the ancestral wild type, single, or
double mutants were the predominant dhps alleles in the east
(Table 1, Fig. 1). The finding of the novel triple mutant dhps allele
SGNGA in high frequency (19.3%) is particularly interesting since
this allele has not been reported from any other malaria endemic
region of the world. The frequency of the SGNGA allele in Pailin
was greater (,45%) than the other highly resistant alleles. In
addition, we found two quadruple mutant dhps alleles (AGEAT
and FGEAT), albeit in low frequency (0.94%), in south Cambodia.
We observed that 581G and 540E/N were always associated with
437G (SGKGA; SGEAA; SGEGA; AGEAA; SGNGA) (Table 1).
Particularly, 540N was always associated with 437G and 581G.
Genetic diversity and pattern of selective sweeps around
dhps alleles
To analyze genetic diversity and investigate the pattern of
selective sweeps around dhps alleles, we measured the number of
alleles (A) and heterozygosity (He) for each of the 10 loci. The
mean number of alleles (A) as well as mean heterozygosity (He) for
the wild type dhps (SAKAA) were greater (A=8.664.1;
He=0.7860.08) compared to dhps alleles harboring single
(A=5.963.2; He=0.6560.06; P=0.052), double (A=4.562.4;
He=0.5660.07; P=0.035), and triple mutations (A=3.661.3;
He=0.3960.07; P=0.005) (Fig. 2A, Fig. S1A; Table S3). This
observation is compatible with these mutations being selected by
drug pressure as indicated by a progressive decline in A and He
Table 1. Prevalence of dhps mutations in Cambodia.
No. of
mutations DHPS alleles
Pailin
n=49
Kampong Seila
n=10
Chumkiri
n=80
Memut
n=37
Rattanakiri
n=36
Total
n=212 (%)
0 SAKAA - - 2 13 8 23 (10.8)
1 AAKAA - - - - 1 1 (0.47)
SGKAA - 3 3 2 13 21 (9.9)
2 AGKAA - - 2 7 7 16 (7.5)
FGKAA - - - - 1 1 (0.47)
SGEAA 3 - 7 12 2 24 (11.3)
SGKGA 5 - 10 - 1 16 (7.5)
3S GEGA 4 1 17 - - 22 (10.3)
SGNGA 22 2 16 1 - 41 (19.3)
AGEAA 15 4 21 2 2 44 (20.7)
AGKAT - - - - 1 1 (0.47)
4 AGEAT - - 1 - - 1 (0.47)
FGEAT - - 1 - - 1 (0.47)
Note: The DHPS alleles are denoted by the single letter amino acid code for codons 436, 437, 540, 581 and 613. Mutated amino acids are boldfaced and underlined.
doi:10.1371/journal.ppat.1000830.t001
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in the dhps gene. Such a trend is consistent with a model of positive
directional selection. To determine if the reduction in variation at
dhps was possibly due to demographic effects, such as a population
bottleneck, we also measured He at 8 neutral loci on chromosomes
2 and 3 that are not known to be under any selection. The mean
Figure 2. Selective sweeps around dhps alleles in Cambodia. (A) Comparison of the wild type and three mutant (single, double and triple)
groups. (B) Comparison of the single (SGKAA) and double mutant (AGKAA, SGEAA, SGKGA) dhps alleles. (C) Comparison of the three triple mutant
(AGEAA, SGEGA, SGNGA) dhps alleles. The dashed line crossing the y-axis indicates the mean heterozygosity (He) at 8 neutral microsatellite loci on
chromosomes 2 and 3. The error bars indicate 61SD (standard deviation).
doi:10.1371/journal.ppat.1000830.g002
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(P=0.016) than the mean He observed at 10 dhps loci. Moreover,
there was no significant difference in He at neutral loci when wild,
single, double and triple mutant groups were compared (Table
S3). Unlike selection which only acts on one or a few loci in a
genome, demographic effects are expected to act on the entire
genome, thus the decline in variation is not likely due to
demographic effects [57]. As shown in Fig. 2A, the valley of
reduced variation for the triple mutant dhps alleles was deeper
followed by the double mutant and single mutant alleles,
suggestive of stronger selection for the triple mutant alleles. With
the exception of the 211 Kb locus, which generally exhibited
lower diversity in both wild type and all mutant groups, there was
sharp reduction in He between 22.9 and 1.4 Kb region.
Since there were three types of double mutant dhps alleles in
Cambodia, known to have different levels of in vitro resistance to
sulfadoxine [13], we tested for differences in the selective sweeps
around them. The double mutant SGKGA (A=1.660.5;
He=0.1360.05) showed significantly lower diversity compared
to AGKAA (A=2.861.2; He=0.4060.06; P=0.01). However,
there was no significant difference between the mean He at
SGEAA (A=2.861.4; He=0.3360.08) compared to SGKGA
(P=0.31) and AGKAA (P=0.52) (Fig. 2B; Fig. S1B). The valley of
reduced variation was also broader for SGKGA compared to the
other two double mutants (Fig. 2B). All three triple mutant alleles
(AGEAA: A=2.761, He=0.2060.05; SGNGA: A=2.360.8,
He=0.1860.06; and SGEGA: A=1.460.5, He=0.1360.06)
showed lower level of diversity with no significant difference
between them (Fig. 2C; Fig. S1C). Interestingly, the valley was
both wider and symmetrical for the SGEGA allele as compared to
the SGNGA and AGEAA alleles (Fig. 2C). This could be the result
of the expansion of few lineages with the SGEGA genotype
because limited genetic variability within the founding population
would broaden the width of the selective sweep. Alternatively, the
SGEGA may have recently evolved with insufficient time for
recombination to break down potential linkage. Although the
mean He for the loci surrounding SGKGA double mutant and
SGEGA triple mutant alleles were almost similar (P=0.48), there
was some difference in the shape of the selection valley at these
alleles (Fig. 2C).
Comparison of genetic differentiation at dhps and
neutral microsatellite loci
The FST between populations (wild, single, double and triple
mutant groups) were compared over 10 dhps and 8 neutral
microsatellite loci as shown in Fig. 3A. As expected, FST values at
all 10 dhps loci differed significantly from zero (Fig. 3A). On the
other hand, three of the neutral loci also exhibited little but
significant differentiation. The overall FST over the 10 dhps loci was
0.20 (SE=0.03, CI=0.15–0.26) and was significantly higher
(Mann-Whitney U test: Z=3.55, P=0.0003) than the overall
FST obtained over the 8 neutral loci (FST=0.01, SE=0.003
CI=0.006–0.019).
The coalescent simulations method of Beaumont and Nichols
[43] was used to disentangle selected loci from those behaving
neutrally. The FST values for all dhps loci fell outside the 95%
confidence interval of neutral expectations, indicative of being
under directional selection or linked to a region of the genome
under selection (Fig. 3B; see Table S4 for P value for deviation
from neutral expectations). On the other hand, only one (C2M34)
of the 8 neutral loci was found to lie marginally outside the 95%
confidence interval (Fig. 3B; Table S4).
The pairwise FST comparisons between populations based on
geography (4 regions in Cambodia) were performed using both
dhps and neutral microsatellite loci (Table 2). The overall FST over
the 10 dhps loci was 0.12, (SE=0.02, CI=0.09–0.16) and was
significantly higher (Mann-Whitney U test: Z=23.1, P=0.0009)
than the overall FST obtained over the 8 neutral loci (FST=0.04,
SE=0.01, CI=0.024–0.060).
Linkage disequilibrium (LD) around dhps alleles
A selective sweep reduces the amount of genetic variation at the
chromosomal region containing a favorable mutation as well as at
loci flanking the mutation, which leads to increased linkage
disequilibrium (LD) around the target of selection. Therefore, in
order to have an assessment of selection, we also measured LD
as a standardized association index (IA
S) between multiple loci
flanking dhps alleles. There was no significant LD after Bonferroni
correction (IA
S=0.019, P=0.06) around the wild type (SAKAA)
allele, whereas significant LD was observed around mutant dhps
alleles. The IA
S for single, double and triple mutant dhps alleles was
0.20 (P,0.01), 0.33 (P,0.01), and 0.22 (P,0.01), respectively.
Multiple origins of resistant dhps alleles in Cambodia
independent from Africa and South America
We estimated the probable number of origin(s) for resistant dhps
alleles in Cambodia based on the 10-loci microsatellite haplotypes
around dhps (allele sizes and haplotypes information are given as
supporting information in Table S5). The 10-loci haplotypes for all
isolates with the wild type dhps allele were unique, showing
complete linkage equilibrium between any two loci (open circles
H1–H20 in Fig. 4A). The emergence of the 437G (SGKAA)
mutation on multiple wild type genetic backgrounds led to an
increase in the LD between loci and limited sharing of
microsatellite haplotypes between the isolates (blue circles,
particularly H21 to H24 in Fig. 4A). We found three major
independent lineages for the double mutant dhps alleles: SGKGA,
SGEAA and AGKAA in Cambodia (Fig. 4A). This was evident
from the lack of shared 10-loci microsatellite haplotypes between
these three alleles (Table S5). The SGKGA alleles shared identical
microsatellite haplotype backgrounds, suggesting a single origin for
this allele (maroon circles labeled H47 to H50 in Fig. 4A).
Although a majority of the SGEAA allele shared common
microsatellite haplotypes, a minority were also found to occur on
diverse backgrounds (green circles in Fig. 4A). A similar scenario
was also observed for the AGKAA allele (black circles in Fig. 4A).
Among the triple mutants, the SGEGA and SGNGA alleles shared
a common origin and appear to have emerged from the SGKGA
double mutant, as indicated by their common haplotype
backgrounds (Fig. 4A, 4B; Table S5). On the other hand, the
AGEAA triple mutant originated from AGKAA on identical or
nearly identical genetic backgrounds, suggesting multiple origins
for this allele or possibly recombination events (Fig. 4A, 4B, Table
S5). We did not find any evidence suggestive of the emergence of
any triple mutant dhps alleles resulting from the SGEAA genetic
background (Fig. 4A, 4B). Thus, our results seem to suggest
multiple but limited origins for the highly resistant dhps alleles in
Cambodia.
We compared the 7-loci microsatellite haplotype of the
Cambodian dhps alleles with the Kenyan (SGEAA) and Camer-
oonian (SGKAA and AGKAA) dhps alleles (Fig. 5). In addition, we
also compared backgrounds of the Cambodian alleles with the
SGKGA and SGEGA alleles from Venezuela. Within Kenya, the
majority of the SGEAA alleles had identical or nearly identical 7-
loci microsatellite haplotypes (Fig. 5). However, a few SGEAA
alleles also had unique haplotypes suggesting independent evolu-
tion of these alleles or recombination events. None of the isolates
in Kenya and Cambodia shared identical 7-loci microsatellite
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independent from Cambodia (Fig. 5). Similarly, unique haplotype
profiles of the SGKAA and AGKAA alleles in Cameroon suggest
multiple origins independent from Cambodia (Fig. 5). The only
triple mutant found in South America (with a common founder) is
SGEGA, and this allele had a completely distinct origin from the
Cambodian SGKGA and SGEGA alleles. The double mutant
SGKGA allele in Venezuela also had a completely distinct
microsatellite haplotype compared to the Cambodian counterparts,
indicating an independent evolution of dhps mutants in the South
American region (Fig. 5).
Discussion
Unlike CQ and pyrimethamine resistance, there is no infor-
mation available on the origins and evolutionary dynamics of
sulfadoxine-resistant dhps alleles in the P. falciparum population
from Southeast Asia. Therefore, the present study was undertaken
to reveal the lineages of the highly resistant dhps alleles in this
region. Samples in this study were analyzed from Pailin on the
Thailand-Cambodia border as well as from four other regions in
eastern and southern Cambodia. The isolates from the east
predominantly had wild type (SAKAA), single mutant (SGKAA),
and double mutant (AGKAA and SGEAA) dhps alleles, whereas
those from the west and south predominantly had SGKGA double
mutant and SGEGA, SGNGA and AGEAA triple mutants. These
findings are in accordance with a previous finding that the
parasites from eastern Cambodia are generally less resistant to SP
(Cambodia National Malaria Control Program, unpublished data).
It is important to note that although SP officially has not been in
use in Cambodia for more than a decade, sulfadoxine-resistant
dhps alleles are rampant in the population. This may also be
Figure 3. Comparison of FST across selected (dhps) and unselected (neutral) loci. (A) Histogram plotting FST (6SD) values at 8 neutral (gray
bars) and 10 dhps (black bars) microsatellite loci. Asterisk indicates significant values obtained after 1000 random permutations. Populations were
defined according to their dhps genotype (i.e. wild type, single, double, or triple mutant) for calculations of the overall (global) FST. The overall FST for
dhps after jackknifing over loci was 0.20 (95% CI: 0.15–0.26) whereas the overall FST for 8 neutral loci was 0.01 (95% CI: 0.006–0.019). The difference
between FST values of dhps and neutral groups was highly significant as assessed by Mann-Whitney U test (Z=3.55, P=0.0003). (B) Plot of FST versus
He to disentangle selection on dhps and neutral loci. Black circles represent 10 dhps loci and white diamonds represent 8 neutral loci. The gray
shading indicates the region of neutral expectations at a confidence level of 95%. The markers above the gray region are considered to be under
directional selection while those inside the gray region are considered to be neutral. The P values (simulated FST,sample FST) for each locus are given
as supporting information (Table S4).
doi:10.1371/journal.ppat.1000830.g003
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counter antimalarial in Cambodia, particularly in rural areas.
Interestingly, almost all mutant dhps alleles (188/189) had the
437G mutation, consistent with its critical role in sulfadoxine
resistance and its wide occurrence globally [24,58,59]. The first
mutation to occur and persist in populations in response to
sulfadoxine pressure is 437G followed by mutations at additional
codons, which lead to progressive increases in the level of
resistance [15]. The 437G (SGKAA) or 437G/540E (SGEAA)
dhps alleles in conjunction with double (51I//59R) or triple (51I/
59R/108N) mutant dhfr alleles have been found to be associated
with SP therapeutic failure in studies from Africa and Asia
[58,59,60,61,62,63,64,65,66,67,68]. Similarly, the 437G/540E/
581G (SGEGA) allele with the dhfr 51I//108N/164L allele has
been correlated with in vivo SP resistance in South America [19].
Approximately 20% of the isolates, mainly from the west and
south Cambodia, harbored a 540N mutation, always in association
with 437G/581G (SGNGA). The Pailin area had ,45% isolates
with this novel triple mutant dhps allele (Table 1). To our
knowledge, this is the first time that this allele has been observed in
any malaria-endemic region of the world. However, it is not
known how and when this new mutation emerged and what role
this mutation plays in the response of the sulfadoxine. Nonetheless,
its mere occurrence on the Thailand-Cambodia border and in
southern Cambodia and strong selective signature around this
allele (Fig. 2), suggest that this mutation may be playing an
important role in sulfadoxine resistance. It is also likely that cross
resistance to related drugs like cotrimoxazole (trimethoprim plus
sulfamethoxazole), may have a role in selection of this allele.
Cotrimoxazole is another antifolate combination widely used to
treat bacterial infections. In one study, dhps mutations were
analyzed in 53 Cambodian isolates, however the 540N mutation
was not found, possibly due to the fact that most of these samples
were from the eastern part of the country [16]. Similarly, we found
only one isolate with the 540N mutation in eastern Cambodia
(Table 1). However, a recent study has reported 540N dhps
mutation in 19 of the 55 P. falciparum isolates from the Car Nicobar
Islands of India, collected in October 2005 almost 9 months after
the December 2004 tsunami, though; it was seen in association
with 436A/437G (AGNAA) [69], unlike what we found in
Cambodia. The 540N mutation was not found in samples
(n=50) collected before the tsunami. Lumb et al. [69] argue that
after the tsunami many patients were simultaneously treated with
two antifolate combinations: SP for malaria and trimethoprim-
sulfamethoxazole for bacterial infections. This strong antifolate
pressure may have allowed the selection of 540N mutation in the
population. Interestingly, this mutation was not seen in samples
collected at four other time points after the tsunami (n=103) [69].
Like SGNGA, the role of the AGNAA dhps allele in sulfadoxine
resistance is yet to be determined.
Asexpected under amodel ofa selective sweep, the dhpsalleleswith
three mutations had the highestreduction in diversity at their flanking
loci, followed by double and single mutant alleles (Fig. 2A). We also
noted that the pattern of selective sweep at each allele was broadly
correlated with the level of in vitro resistance to sulfadoxine. The triple
mutant allele AGEAA had greater reduction in heterozygosity
(inhibitory constant for sulfadoxine, Ki=98.367.5 mM) followed by
SGKGA (Ki=16.262.7 mM), SGEAA (Ki=27.766.1 mM), AG-
KAA (Ki=19.964.0 mM), SGKAA (Ki=1.3960.23 mM) and
SAKAA (wild type, Ki=0.1460.01 mM) [13]. The reduction in
heterozygosity due to a selective sweep was greatest for the SGEGA
and SGNGA triple mutant alleles indicating stronger selection for
thesealleles (Fig. 2C).However, the Ki’softheseallelesforsulfadoxine
are not known.
Underlying population structure may influence the amount of
gene flow between resistant parasites, clouding estimates of
selection. However, we have shown there are few barriers to gene
flow either based on mutation or geography using the neutral loci
(Fig. 3A and Table 2). Our estimates of global FST using the
neutral microsatellite loci are below 0.05 using either geography or
mutation to partition variation in Cambodia, indicating little
genetic structuring in this population of P. falciparum. In contrast,
quite high estimates of FST (greater than 0.12) are obtained using
the microsatellite loci surrounding dhps (Fig. 3A) clearly supporting
a role for strong selective pressure on this gene. Further, the FST
outlier analysis also suggest that all 10 dhps loci have statistically
higher FST values than expected under neutrality (Fig. 3B; Table
S4), supporting that these loci are subject to directional selection.
The present data suggest three major independent origins of
double mutant dhps alleles in Cambodia. The 437G mutation
(SGKAA) was found to occur on multiple genetic backgrounds
with subsequent mutations at 540, 436 and 581 producing the
double mutants SGEAA, AGKAA and SGKGA, respectively
(Fig. 4B). In accordance, the microsatellite haplotype backgrounds
of these three double mutants were distinct from each other (Panel
C, D and E in Table S5). Further, the SGKGA double mutant
after acquiring 540E or 540N gave rise to SGEGA or SGNGA
triple mutants, respectively, which is strongly supported by their
common microsatellite backgrounds (Fig. 4B, Panel C of Table
S5). Thus, SGEGA and SGNGA alleles have a common origin
from the double mutant SGKGA. The SGKGA and SGEGA
alleles in South America also have been found to share single and
common haplotype backgrounds [21] yet different from Cambo-
dia. At this point, we do not know whether 540E and 540N
mutation in Cambodia simultaneously emerged and rose in
frequency under sulfadoxine pressure or if they emerged at
different time points. Analysis of the retrospective samples from
this region may provide some clue on this aspect. However,
because the 540E mutation is so widespread, it is likely that this
would have been the first mutation to occur followed by 540N.
Similarly, the widely spread triple mutant dhps allele AGEAA in
Asia [17,18] likely resulted from the AGKAA double mutant
acquiring the mutation at codon 540. As shown in Fig. 4A (also in
panel D of Table S5), the double and triple mutants share identical
haplotype backgrounds, reaffirming their shared origin. It is likely
that the novel AGNAA triple mutant allele observed on the Car
Nicobar Islands [69] may have also emerged on the AGKAA
Table 2. Pairwise FST comparisons between four populations
in Cambodia.
PL CK MM RK
PL 0.052 0.017 0.041
CK 0.002 0.045 0.059
MM 0.162 0.175 0.011
RK 0.160 0.180 20.005
Note: Populations were defined according to geographic locations. Pailin: PL
(n=36); Chumkiri: CK (n=50); Memut: MM, (n=28); and Rattanakiri: RK (n=27).
Because there were only 7 singly-infected isolates from Kampong Seila these
were combined with the PL population. FST values calculated from 10 dhps loci
are given below the diagonal while those above are calculated from the 8
neutral loci. The values in bold indicate significant FST after Bonferroni
correction (P#0.008) for multiple comparisons. Overall FST value for dhps
after jackknifing over loci was 0.1260.02 (95% CI obtained after 1000
bootstrapping over loci: 0.09–0.16) and for neutral loci FST was 0.0460.01
(95% CI: 0.024–0.060).
doi:10.1371/journal.ppat.1000830.t002
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PLoS Pathogens | www.plospathogens.org 8 March 2010 | Volume 6 | Issue 3 | e1000830Figure 4. Genetic relationships among dhps alleles in Cambodia. (A) A median-joining network diagram depicting three independent origins
for double mutant and two independent origins for triple mutant dhps alleles in Cambodia. The 141 P. falciparum isolates were classified into 85
haplotypes (H1 to H85; see individual haplotypes profiles in Table S5) based on the 10-loci microsatellite profile around dhps gene. The size of the
circle is proportional to the number of isolates showing particular 10-loci microsatellite haplotype, the proportion of dhps alleles on that haplotype
background are depicted by the pie charts. The red dots are hypothetical median vectors generated by the software to connect existing haplotypes
within the network with maximum parsimony. Box 1, 2 and 3 indicate three major origins for dhps mutant alleles. (B) Scheme of plausible evolution of
dhps alleles inferred from the microsatellite haplotypes data. Three major and independent lineages are proposed for the double mutants, one each
for SGKGA, SGEAA and AGKAA. The SGKGA is the progenitor allele for SGEGA and SGNGA triple mutants, whereas AGKAA is the progenitor for AGEAA
triple mutant. Most likely, the AGKAA double mutant could also be the progenitor of AGNAA triple mutant found on the Andaman and Nicobar
Islands, given its wide occurrence on the islands.
doi:10.1371/journal.ppat.1000830.g004
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that there are three major independent origins for the double
mutant dhps alleles and two major independent origins for the
triple mutant alleles in Cambodia (Fig. 4).
Gene flow plays an important role in the spread of drug resistant
mutations as has been seen in the case of CQ and pyrimethamine
resistance. Genetic evidence suggests that CQ and pyrimethamine
resistance originated on the Thailand-Cambodia border and
spread to Africa in the late 1970s and mid 1980s, respectively
[26,31,70]. Thus, we also attempted to understand the evolution-
ary relationships between the Southeast Asian, African and South
American dhps alleles. Results suggest that the SGEGA alleles both
in South America [20,21] and Cambodia evolved independently
(Fig. 5). In a recent study, Pearce et al. [24] attempted to
understand the origin and dispersal of sulfadoxine resistance in
Africa by analyzing three microsatellite loci flanking the dhps gene.
Based on the data from several African countries it has been
concluded that the sulfadoxine resistance-conferring dhps alleles in
east Africa (predominantly SGEAA) are different from those in
west Africa (SGKAA and AGKAA) and these alleles are associated
with multiple genetic backgrounds consisting of five major lineages
[24]. This corroborates with our previous data [25] as well as the
present study, which confirms multiple, independent origins of the
above dhps alleles in east and west Africa (Fig. 5). None of the triple
mutant dhps alleles reported in other parts of the world has
appeared in Africa. It remains to be seen whether a triple mutant
dhps allele will independently evolve in Africa or expand from
migration of parasites from other parts of the world, as in the case
of triple mutant dhfr. It is surprising though that the major triple
mutant dhfr allele found in Africa is believed to have been
imported from Southeast Asia and spread across the continent
while none of the triple mutant dhps alleles have been established in
Africa. One possibility may be that the introduction of dhfr mutant
allele may have preceded the development of triple mutant dhps
allele.
In conclusion, results from this study reveal some very
interesting findings: i) presence of a novel triple mutant dhps
SGNGA as a predominant allele in Cambodia along with two
previously reported triple mutant alleles SGEGA and AGEAA; ii)
the triple mutant dhps alleles were present at high frequencies in
the western and southern parts of Cambodia while they were
rarely seen in the east, indicating that sulfadoxine resistance may
be a lesser problem in the east; iii) the triple mutant dhps alleles
have not declined over several years after SP was officially
removed as the drug of choice for the primary treatment of
malaria in this region; iv) at least three independent origins of the
double mutants and two independent origins of triple mutant dhps
alleles are evident in Cambodia; v) the origin of triple mutant dhps
allele SGEGA in South America is completely distinct from the
Cambodian SGEGA allele; vi) the double mutant SGEAA allele in
Kenya and AGKAA allele in Cameroon are evolutionary distinct
from their counterparts in Cambodia, indicating multiple origins
for these alleles. Finally, it is also evident that unlike pfcrt and dhfr
resistant alleles, which have single origin in Thailand-Cambodia
region, the dhps resistant alleles have multiple origins in this region.
Thus, we have provided comprehensive new data illustrating
multiple global origins for sulfadoxine resistant dhps alleles.
Supporting Information
Table S1 List of primers used to amplify 10 microsatellite loci
around dhps gene
Found at: doi:10.1371/journal.ppat.1000830.s001 (0.03 MB
DOC)
Table S2 Distribution of the DHPS genotypes in the 22
multiply-infected P. falciparum samples
Figure 5. Genetic relationships among the dhps alleles of Southeast Asia (Cambodia), Africa (Kenya and Cameroon) and South
America (Venezuela). An eBURST diagram showing major lineages for Cambodian dhps alleles. Two major lineages exist in Cameroon (SGKAA and
AGKAA), one major lineage in Kenya (SGEAA), and one in Venezuela (SGKGA and SGEGA). Each lineage is distinct from the others, suggesting
multiple, independent evolutionary histories.
doi:10.1371/journal.ppat.1000830.g005
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Table S3 The expected heterozygosity (He) and number of
alleles (A) at 10 microsatellite loci around dhps gene and at 8 loci on
chromosomes 2 and 3 in Cambodia.
Found at: doi:10.1371/journal.ppat.1000830.s003 (0.07 MB
DOC)
Table S4 Sample He and sample FST at all 10 dhps and 8 neutral
microsatellite loci as obtained in LOSITAN
Found at: doi:10.1371/journal.ppat.1000830.s004 (0.04 MB
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Table S5 The 10-loci microsatellite haplotype profiles of the dhps
alleles in Cambodia
Found at: doi:10.1371/journal.ppat.1000830.s005 (0.04 MB PDF)
Figure S1 Box-and-Whisker plot comparing the heterozygosities
(He) around dhps alleles in Cambodia. The box indicates the
median (horizontal solid line inside the box) and interquartile
range (25th and 75th percentiles) and the whiskers indicate the
range (upper and lower He values). The outliers are shown as solid
black diamonds. The difference between each group was
compared using Mann-Whitney U test and P values#0.05 were
considered significant. Statistically significant differences are
indicated above the box by P values. (A) He comparison between
wild (n=20), single (n=17), double (n=37) and triple (n=65)
mutant dhps alleles. (B) He comparison between SGKAA (n=16),
AGKAA (n=10), SGEAA (n=14) and SGKGA (n=12) dhps
alleles. (C) He comparison between SGKGA (n=12), AGEAA
(n=26), SGNGA (n=27), SGEGA (n=11) dhps alleles. Similar
analyses were also done for all neutral microsatellite loci,
however none of the comparison produced statistically significant
difference.
Found at: doi:10.1371/journal.ppat.1000830.s006 (0.94 MB TIF)
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